PRESS RELEASE published on 06/18/2025 at 12:30, 1 year 3 months ago With Rising Variants of COVID and Bird Flu, the Single Broad-Spectrum Antiviral NV-387 Would be the Best Partner for Preparedness, Says NanoViricides' Dr. Diwan NanoViricides, Inc. announces the effectiveness of broad-spectrum antiviral drug NV-387 against COVID variants and Bird Flu, positioning it well for pandemic preparedness NanoViricides NV-387 Antiviral Drug Bird Flu COVID Variants
BRIEF published on 06/04/2025 at 13:00, 1 year 3 months ago NanoViricides Prepares for Measles Drug Animal Study NanoViricides NV-387 Measles Outbreak Vaccine Decline Antiviral Study
BRIEF published on 06/04/2025 at 13:00, 1 year 3 months ago NanoViricides se prépare à une étude animale sur un médicament contre la rougeole NanoViricides NV-387 Épidémie De Rougeole Déclin Des Vaccins Étude Antivirale
PRESS RELEASE published on 06/04/2025 at 12:55, 1 year 3 months ago NanoViricides Measles Drug Development Animal Study is Imminent NanoViricides, Inc. announces progress in developing a Measles drug, NV-387, a broad-spectrum antiviral with potential to combat Measles outbreaks and vaccine failures NV-387 NanoViricides Inc. Antiviral Clinical Stage Measles Drug
BRIEF published on 05/28/2025 at 12:35, 1 year 4 months ago NanoViricides to Showcase at Boston's BIO International Convention NanoViricides Broad-spectrum Antiviral NV-387 Drug BIO Convention 2025 Platform Technologies
BRIEF published on 05/28/2025 at 12:35, 1 year 4 months ago NanoViricides sera présenté à la convention internationale BIO de Boston NanoViricides Antiviral À Large Spectre Médicament NV-387 Convention BIO 2025 Technologies De Plate-forme
PRESS RELEASE published on 05/28/2025 at 12:30, 1 year 4 months ago NanoViricides to Present at the BIO International Convention in Boston on Monday, June 16, 2025 NanoViricides to present at BIO International Convention 2025 on June 16 in Boston, MA, showcasing breakthrough antiviral drug NV-387 with broad-spectrum efficacy and unique mechanism NanoViricides NV-387 BIO International Convention Antiviral Drug Clinical Stage
BRIEF published on 05/22/2025 at 12:35, 1 year 4 months ago NanoViricides Comments on New FDA COVID Vaccine Policy FDA NanoViricides Antiviral Drugs COVID Vaccine Policy Public Health Strategy
BRIEF published on 05/22/2025 at 12:35, 1 year 4 months ago NanoViricides commente la nouvelle politique de la FDA concernant les vaccins contre la COVID-19 FDA NanoViricides Médicaments Antiviraux Politique De Vaccination Contre La COVID Stratégie De Santé Publique
PRESS RELEASE published on 05/22/2025 at 12:30, 1 year 4 months ago The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr. Diwan NanoViricides, Inc. comments on the new COVID Vaccine Booster Shots policy adopted by the US FDA with focus on specific high-risk groups. Dr. Anil Diwan emphasizes evidence-based decision making for vaccine boosters NanoViricides Inc. COVID Vaccine Booster Shots US FDA Policy Vaccine Effectiveness Dr. Anil Diwan
Published on 09/29/2026 at 16:45, 1 hour 36 minutes ago Gold Terra Announces Visible Mineralization in Hole CMUP-005 in Early Sonic Drilling at the Con Mine Historical Tailings, Yellowknife, NWT
Published on 09/29/2026 at 15:00, 3 hours 21 minutes ago As Crisis Events Intensify, BlackBerry and the American Red Cross Renew Commitment to Secure and Trusted Emergency Communications
Published on 09/29/2026 at 14:45, 3 hours 36 minutes ago NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials
Published on 09/29/2026 at 14:30, 3 hours 51 minutes ago Solitario Resources Presentation Change of Time at the 38th Annual Mining Forum Americas 2026 Conference
Published on 09/29/2026 at 18:00, 21 minutes ago Waga Energy va produire du biométhane près de Grenade (Espagne)
Published on 09/29/2026 at 18:00, 21 minutes ago Waga Energy to produce RNG from landfill gas near Granada, Spain
Published on 09/29/2026 at 18:00, 21 minutes ago VOYAGEURS DU MONDE : Croissance du chiffre d'affaires
Published on 09/29/2026 at 17:40, 41 minutes ago Infotel : Mise à disposition du rapport financier semestriel 2026.
Published on 09/29/2026 at 17:40, 41 minutes ago LDC : Nombre total de droits de vote et d'actions composant le capital au 31.08.26.
Published on 09/29/2026 at 14:15, 4 hours 5 minutes ago 260929 BENETEAU Mise en oeuvre du programme de rachat d'actions
Published on 09/29/2026 at 12:15, 6 hours 5 minutes ago NRJ GROUP - Affaire Fun Radio - Report du délibéré de la Cour d'appel
Published on 09/29/2026 at 08:45, 9 hours 36 minutes ago Cegedim Santé réinvente l’accès à l’information médicale en déployant l’Assistant by Claude Bernard IA sur toutes ses solutions de médecine de ville